Apitolisib
Chemical Structure Depiction of
Apitolisib
Apitolisib
Compound characteristics
| Compound ID: | CE02-3282 |
| Compound Name: | Apitolisib |
| Molecular Weight: | 498.61 |
| Molecular Formula: | C23 H30 N8 O3 S |
| CAS Number: | 1032754-93-0 |
| Smiles: | Cc1c2c(c(nc(c3cnc(N)nc3)n2)N2CCOCC2)sc1CN1CCN(CC1)C([C@H](C)O)=O |
| InChI Key: | YOVVNQKCSKSHKT-HNNXBMFYSA-N |
| Short Description: | Apitolisib (RG 7422), an effective, class I PI3K inhibitor for PI3Kalpha(IC50=5 nM), PI3Kbeta(IC50=27 nM), PI3Kdelta(IC50=7 nM), PI3Kgamma (IC50=14 nM), is used in trials study of solid cancers, breas t cancer, prostate cancer, renal cell carcinoma, and endometrial carcinoma, among others. |
| Pathway: | Apoptosis|||PI3K/Akt/mTOR signaling |
| Target: | Apoptosis|||PI3K|||mTOR |
| Type of molecule: | Clinical |
| Alias: | RG 7422 , GNE 390 , GDC-0980 |
| Stock amount: | 1086 |